Skip to main content
. Author manuscript; available in PMC: 2018 Sep 21.
Published in final edited form as: Mol Psychiatry. 2017 May 2;23(7):1555–1565. doi: 10.1038/mp.2017.91

Figure 5.

Figure 5

A) 24 hr food intake and body weight following mPFC administration of AP-5 or vehicle (VEH) and vHP administration of exendin-4 (EX-4) or VEH. B) 24 hr food intake and body weight following mPFC administration of CNQx or VEH and vHP administration of EX-4 or VEH. C) Phosphorylated NR2B expression in the mPFC following unilateral vHP delivery of exendin-4 or vehicle. *p<0.05. Data are mean ± SEM.